Potential applications of molecular biology in neuroendocrine tumors

Endocrine Pathology

Volumn 14, Issue 4, 2003, Pages 319-328

  Emmer, Tommaso ^a   Volante, Marco ^a   Pagani, Alberto ^b   Allia, Elena ^a   Crafa, Pellegrino ^c   Bussolati, Gianni ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b Pathology   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Clonality; Differentiation; Hormone receptors; Molecular biology; Multiple endocrine neoplasia; Neuroendocrine; PCR

Indexed keywords

HORMONE RECEPTOR; OXYTOCIN; PEPTIDE HORMONE; SOMATOSTATIN;

ADENOMA; CANCER DIAGNOSIS; CARCINOMA; CELL DIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; ENDOCRINE DISEASE; FOLLOW UP; GENE DELETION; GENE MUTATION; HUMAN; HYPERPLASIA; MIXED TUMOR; MOLECULAR BIOLOGY; MOLECULAR CLONING; MUTATION; NEUROENDOCRINE DISEASE; NEUROENDOCRINE TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS;

CLONE CELLS; GENE DELETION; HUMANS; MUTATION; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, PEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 3142588775     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:14:4:319     Document Type: Conference Paper

References (39)

1. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407, 1997.
2. Yaguchi H, Ohkura N, Tsukada T, Yamaguchi K. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem 277:38197-38204, 2002.
3. Tsukada T, Yamaguchi K, Kameya T. The MEN1 gene and associated diseases: an update. Endocr Pathol 12:259-273, 2001.
4. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571-578, 1988.
5. Pasini B, Ceccherini I, Romeo G. RET mutations in human disease. Trends Genet 12:138-144, 1996.
6. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671, 2001.
7. Komminoth P, Kunz EK, Matias-Guiu X, et al. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer 76:479-489, 1995.
8. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161:1961-1971, 2002.
9. Komminoth P, Muletta-Feurer S, Saremaslani P, et al. Molecular diagnosis of multiple endocrine neoplasia (MEN) in paraffin-embedded specimens. Endocr Pathol 6:267-278, 1995.
10. Komminoth P, Roth J, Muletta-Feurer S, Saremaslani P, Seelentag WK, Heitz PU. RET proto-oncogene point mutations in sporadic neuroendocrine tumors. J Clin Endocrinol Metab 81:2041-2046, 1996.
11. Gortz B, Roth J, Krahenmann A, et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 154:429-436, 1999.
12. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046, 2001.
13. van Dijk JP, Heuver LH, van der Reijden BA, Raymakers RA, de Witte T, Jansen JH. A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reaction. Am J Pathol 161:807-812, 2002.
14. Marques AR, Catarino AL, Moniz S, et al. Medullary carcinomas of the thyroid: a monoclonal origin. Thyroid 11:1109-1113, 2001.
15. Ferraris AM, Mangerini R, Gaetani GF, Romei C, Pinchera A, Pacini F. Polyclonal origin of medullary carcinoma of the thyroid in multiple endocrine neoplasia type 2. Hum Genet 99:202-205, 1997.
16. Friedman E, Sakaguchi K, Bale AE, et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213-218, 1989.
17. Sanjuan X, Bryant BR, Sobel ME, Merino MI. Clonality analysis of benign parathyroid lesions by human androgen receptor (HUMARA) gene assay. Endocr Pathol 9:293-300, 1998.
18. Shan L, Nakamura M, Nakamura Y, et al. Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism. Virchows Arch 430:247-251, 1997.
19. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drucke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053, 1995.
20. Perren A, Roth J, Muletta-Feurer S, et al. Clonal analysis of sporadic pancreatic endocrine tumours. J Pathol 186:363-371, 1998.
21. D'Adda T, Candidus S, Denk H, Bordi C, Hofler H. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions. J Pathol 189:394-401, 1999.
22. Goebel SU, Vortmeyer AO, Zhuang Z, Serrano J, Jensen RT, Lubensky IA. Identical clonality of sporadic gastrinomas at multiple sites. Cancer Res 60:60-63, 2000.
23. Volante M, Papotti M, Roth J, et al. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499-1509, 1999.
24. Ubiali A, Benetti A, Papotti M, Villanacci V, Rindi G. Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases. Virchows Arch 439:776-781, 2001.
25. Pan J, Yeger H, Cutz E. Neuronal developmental marker FORSE-1 identifies a putative progenitor of the pulmonary neuroendocrine cell lineage during lung development. J Histochem Cytochem 50:1567-1578, 2002.
26. Anbazhagan R, Tihan T, Bornman DM, et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res 59:5119-5122, 1999.
27. Ball DW, Azzoli CG, Baylin SB, et al. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 90:5648-5652, 1993.
28. Coulson JM, Edgson JL, Woll PJ, Quinn JP. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res 60:1840-1844, 2000.
29. Grabowski P, Schonfelder J, Ahnert-Hilger G, et al. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 441:256-263, 2002.
30. Weber T, Klar E. Minimal residual disease in thyroid carcinoma. Semin Surg Oncol 20:272-277, 2001.
31. Sailer B, Feldmann G, Haupt K, et al. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer. J Clin Endocrinol Metab 87:292-296, 2002.
32. Pagani A, Macri L, Faulkner LB, et al. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology. Diagn Mol Pathol 11:98-106, 2002.
33. Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer 72:340-344; 1997.
34. Cassoni P, Sapino A, Stella A, Fortunati N, Bussolati G. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. Int J Cancer 77:695-700, 1998.
35. Cassoni P, Fulcheri E, Carcangiu ML, Stella A, Deaglio S, Bussolati G. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance. J Pathol 190:470-477; 2000.
36. Cassoni P, Sapino A, Deaglio S, et al. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk. Cancer Res 62:2406-2413; 2002.
37. Pequeux C, Breton C, Hendrick JC, et al. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. Cancer Res 62:4623-4629, 2002.
38. 111In-labeled 1,4,7,10-tetraazacyclododecane-N,N′,N″, N‴-tetra-acetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors. Cancer Res 61:4393-4397; 2001.
39. Giordano TJ. Gene expression profiling of endocrine tumors using DNA microarrays: progress and promise. Endocr Pathol 14:107-116, 2003.